#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	13336	16S	1529	1529	99.93	16S.l6.c30.ctg.1	2062	635.0	0	.	n	.	0	C451T	SNP	451	451	C	677	677	T	764	T,C	396,353	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	13336	16S	1529	1529	99.93	16S.l6.c30.ctg.1	2062	635.0	1	SNP	n	C1184T	0	.	.	1184	1184	C	1410	1410	C	748	C	725	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	13336	16S	1529	1529	99.93	16S.l6.c30.ctg.1	2062	635.0	0	HET	.	.	.	C207T,A	.	207	207	C	433	433	C	714	C,T,A	553,133,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	25014	23S	2890	2890	99.86	23S.l6.c30.ctg.1	3882	635.5	0	.	n	.	0	T695C	SNP	695	695	T	1303	1303	C	765	C,T	746,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	25014	23S	2890	2890	99.86	23S.l6.c30.ctg.1	3882	635.5	0	.	n	.	0	G888A	SNP	888	888	G	1496	1496	A	781	A,G	537,195	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	25014	23S	2890	2890	99.86	23S.l6.c30.ctg.1	3882	635.5	0	.	n	.	0	A1638G	SNP	1638	1638	A	2246	2246	G	806	G,A	564,208	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	25014	23S	2890	2890	99.86	23S.l6.c30.ctg.1	3882	635.5	0	.	n	.	0	T1971C	SNP	1971	1971	T	2579	2579	C	787	C,A	764,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	25014	23S	2890	2890	99.86	23S.l6.c30.ctg.1	3882	635.5	1	SNP	n	A2045G	0	.	.	2045	2045	A	2653	2653	A	784	A	766	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	25014	23S	2890	2890	99.86	23S.l6.c30.ctg.1	3882	635.5	1	SNP	n	C2597T	0	.	.	2597	2597	C	3205	3205	C	738	C,T,G	723,1,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_V_01427c	folP.WHO_V_01427c	1	1	27	1522	folP	855	855	100.0	folP.l15.c4.ctg.1	1664	90.0	1	SNP	p	R229S	1	.	.	685	687	AGC	1104	1106	AGC	135;136;136	A;G;C	133;134;132	folP.WHO_V_01427c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5258	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3396	152.4	1	SNP	p	S91F	1	.	.	271	273	TTC	546	548	TTC	165;165;167	T;T;C	159;163;161	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5258	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3396	152.4	1	SNP	p	G95N	0	.	.	283	285	GGC	558	560	GGC	162;161;158	G;G;C	153;155;153	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5258	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3396	152.4	1	SNP	p	D95G	1	.	.	283	285	GGC	558	560	GGC	162;161;158	G;G;C	153;155;153	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_G_01393	mtrR.WHO_G_01393	1	1	27	1450	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1287	110.4	1	SNP	p	G45D	0	.	.	133	135	GGC	409	411	GGC	180;177;178	G;G;C	174;173;174	mtrR.WHO_G_01393:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	796	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c17.ctg.1	1027	76.2	0	.	n	.	0	A197.	DEL	197	197	A	561	561	A	174	A	169	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4978	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3074	159.9	1	SNP	p	D86N	0	.	.	256	258	GAC	675	677	GAC	176;175;177	G;A,C;C	173;165,1;173	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4978	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3074	159.9	1	SNP	p	R87I	0	.	.	259	261	CGT	678	680	CGT	176;174;178	C,T;G;T	173,1;172;174	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4978	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3074	159.9	1	SNP	p	R87W	0	.	.	259	261	CGT	678	680	CGT	176;174;178	C,T;G;T	173,1;172;174	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4978	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3074	159.9	1	SNP	p	S87R	1	.	.	259	261	CGT	678	680	CGT	176;174;178	C,T;G;T	173,1;172;174	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4978	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3074	159.9	1	SNP	p	S88P	0	.	.	262	264	TCC	681	683	TCC	180;183;182	T;C;C	176;178;179	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	3600	parE	1986	1986	100.0	parE.l6.c4.ctg.1	2559	138.1	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1548	1550	GGC	163;159;159	G;G;C,A	160;156;153,1	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.34.001	penA.34.001	1	1	27	3536	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2454	142.0	1	SNP	p	A311V	0	.	.	931	933	GCC	1344	1346	GCC	208;209;210	G;C;C	201;202;203	penA.34.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3536	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2454	142.0	1	SNP	p	I312M	1	.	.	934	936	ATG	1347	1349	ATG	209;208;207	A;T;G,T	203;202;198,1	penA.34.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3536	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2454	142.0	1	SNP	p	V316T	1	.	.	946	948	ACC	1359	1361	ACC	204;204;204	A;C;C	191;198;199	penA.34.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3536	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2454	142.0	1	SNP	p	T316P	0	.	.	946	948	ACC	1359	1361	ACC	204;204;204	A;C;C	191;198;199	penA.34.001:1:1:T316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3536	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2454	142.0	1	SNP	p	T483S	0	.	.	1447	1449	ACC	1860	1862	ACC	167;167;167	A;C;C	158;164;163	penA.34.001:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3536	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2454	142.0	1	SNP	p	A501P	0	.	.	1501	1503	GCG	1914	1916	GCG	167;167;166	G;C;G	163;165;162	penA.34.001:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3536	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2454	142.0	1	SNP	p	A501V	0	.	.	1501	1503	GCG	1914	1916	GCG	167;167;166	G;C;G	163;165;162	penA.34.001:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3536	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2454	142.0	1	SNP	p	G542S	0	.	.	1624	1626	GGT	2037	2039	GGT	128;126;125	G;G,C;T,C	126;123,1;121,1	penA.34.001:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3536	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2454	142.0	1	SNP	p	G545S	1	.	.	1633	1635	AGC	2046	2048	AGC	117;115;113	A;G;C	111;110;110	penA.34.001:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3536	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2454	142.0	1	SNP	p	P551S	0	.	.	1651	1653	CCG	2064	2066	CCG	92;92;94	C,G;C;G,C	83,2;81;84,1	penA.34.001:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	5516	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3133	173.4	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1595	1597	CCG	210;210;210	C;C;G	201;205;200	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2254	porA	1146	1146	99.91	porA.l15.c4.ctg.1	1867	118.5	0	.	p	.	0	M83fs	FSHIFT	247	247	A	572	572	C	147	C,G	139,1	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	252	porB1a	984	271	91.51	porB1a.l15.c30.ctg.2	381	23.2	0	.	p	.	0	A251V	NONSYN	751	753	GCG	72	74	GTA	30;30;30	G;T;A	27;26;27	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	252	porB1a	984	271	91.51	porB1a.l15.c30.ctg.2	381	23.2	0	.	p	.	0	S271T	NONSYN	811	813	TCG	132	134	ACT	52;50;48	A;C;T	48;47;45	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	252	porB1a	984	271	91.51	porB1a.l15.c30.ctg.2	381	23.2	0	.	p	.	0	Y273D	NONSYN	817	819	TAT	138	140	GAT	41;37;36	G;A;T	40;37;36	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	252	porB1a	984	271	91.51	porB1a.l15.c30.ctg.2	381	23.2	0	.	p	.	0	D276N	NONSYN	826	828	GAT	147	149	AAC	36;36;36	A;A;C	35;35;36	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	252	porB1a	984	271	91.51	porB1a.l15.c30.ctg.2	381	23.2	0	.	p	.	0	N277H	NONSYN	829	831	AAC	150	152	CAC	36;36;36	C;A;C	36;35;36	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	252	porB1a	984	271	91.51	porB1a.l15.c30.ctg.2	381	23.2	0	.	p	.	0	R307E	NONSYN	919	921	AGA	240	242	GAA	11;11;12	G;A;A	11;11;12	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	252	porB1a	984	271	91.51	porB1a.l15.c30.ctg.2	381	23.2	0	.	p	.	0	T311A	NONSYN	931	933	ACA	252	254	GCA	12;12;13	G;C;A	12;12;13	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	252	porB1a	984	271	91.51	porB1a.l15.c30.ctg.2	381	23.2	0	.	p	.	0	E312D	NONSYN	934	936	GAA	255	257	GAC	12;12;12	G;A;C	12;12;12	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	252	porB1a	984	271	91.51	porB1a.l15.c30.ctg.2	381	23.2	0	.	p	.	0	F314I	NONSYN	940	942	TTC	261	263	ATC	12;12;12	A;T;C	12;12;12	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	252	porB1a	984	271	91.51	porB1a.l15.c30.ctg.2	381	23.2	0	.	p	.	0	A316S	NONSYN	946	948	GCG	267	269	TCG	10;10;10	T;C;G	10;10;10	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	252	porB1a	984	271	91.51	porB1a.l15.c30.ctg.2	381	23.2	0	.	p	.	0	V318A	NONSYN	952	954	GTC	273	275	GCC	10;11;11	G;C;C	10;11;11	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	252	porB1a	984	271	91.51	porB1a.l15.c30.ctg.2	381	23.2	0	.	p	.	0	G319S	NONSYN	955	957	GGC	276	278	AGC	11;11;11	A;G;C	11;11;11	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	252	porB1a	984	271	91.51	porB1a.l15.c30.ctg.2	381	23.2	0	.	p	.	0	G320A	NONSYN	958	960	GGT	279	281	GCC	12;12;12	G;C;C	12;12;12	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	252	porB1a	984	271	91.51	porB1a.l15.c30.ctg.2	381	23.2	0	.	p	.	0	G322V	NONSYN	964	966	GGT	285	287	GTT	11;11;11	G;T;T	11;11;11	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2788	porB1b	1038	1038	99.81	porB1b.l6.c4.ctg.1	1639	167.4	0	.	p	.	0	V37I	NONSYN	109	111	GTA	428	430	ATA	187;185;187	A;T;A	179;181;182	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2788	porB1b	1038	1038	99.81	porB1b.l6.c4.ctg.1	1639	167.4	0	.	p	.	0	I45V	NONSYN	133	135	ATT	452	454	GTT	199;199;199	G;T;T	197;195;195	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2788	porB1b	1038	1038	99.81	porB1b.l6.c4.ctg.1	1639	167.4	1	SNP	p	G120K	1	.	.	358	360	AAG	677	679	AAG	246;240;241	A;A;G	229;228;222	porB1b.WHO_Y_02277c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2788	porB1b	1038	1038	99.81	porB1b.l6.c4.ctg.1	1639	167.4	1	SNP	p	N121D	0	.	.	361	363	AAC	680	682	AAC	241;238;237	A;A,C;C	229;229,1;229	porB1b.WHO_Y_02277c:1:1:N121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2788	porB1b	1038	1038	99.81	porB1b.l6.c4.ctg.1	1639	167.4	1	SNP	p	A121N	1	.	.	361	363	AAC	680	682	AAC	241;238;237	A;A,C;C	229;229,1;229	porB1b.WHO_Y_02277c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	9768	rpoB	4179	4179	99.98	rpoB.l6.c30.ctg.1	4949	194.5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1178	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1130	102.5	1	SNP	p	V57M	1	.	.	169	171	ATG	501	503	ATG	230;229;232	A;T,A;G	225;223,1;227	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
